Fig. 8: The schematic summary demonstrating the role of EBV-miR-BART22 in NPC metastasis.
EBV-miR-BART-22 plays an oncogenic role by driving the EMT and metastasis of NPC by targeting MOSPD2 and activating the Wnt/β-catenin pathway.
Fig. 8: The schematic summary demonstrating the role of EBV-miR-BART22 in NPC metastasis. | Cell Death & Disease
